Moshe Arkin - 18 Mar 2026 Form 3 Insider Report for Sol-Gel Technologies Ltd. (SLGL)

Reporting relationship: Chairman of Board and CEO, Director, 10%+ Owner
Issuer ticker: SLGL
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 18 Mar 2026, 12:12:48 UTC
Prior SEC filing: 10 Feb 2025
Next SEC filing: 27 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/Eyal Ben-Or, Attorney-in-Fact

Key filing fact

Moshe Arkin filed Form 3 for Sol-Gel Technologies Ltd. (SLGL) on 18 Mar 2026.

Key facts

This page summarizes Moshe Arkin's Form 3 filing for Sol-Gel Technologies Ltd. (SLGL).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 18 Mar 2026, 12:12.

Change

Previous filing in this sequence was filed on 10 Feb 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001321178 Primary reporting owner

Arkin Moshe

Relationship: Chairman of Board and CEO, Director, 10%+ Owner
Address: C/O SOL-GEL TECHNOLOGIES LTD., 7 GOLDA MEIR STREET, NESS ZIONA, ISRAEL
Signature: /s/Eyal Ben-Or, Attorney-in-Fact
Signature date: 18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SLGL holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 143,257
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F1

SLGL holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,606,856
Date: 18 Mar 2026
Ownership: By M. Arkin Dermatology Ltd.
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SLGL holding Derivative

Warrants (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: By M. Arkin Dermatology Ltd.
Underlying class: Ordinary Shares
Underlying amount: 200,000
Exercise price: $58.50
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Ordinary shares, NIS 1.00 par value per share.

Footnote F2

The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC remarks

Exhibit 24 - Power of Attorney